473258-19-4

Basic information

• Product Name: Propanoic acid, 2-[(3-chloro-4-fluorophenyl)hydrazono]-, ethyl ester
• CAS NO: 473258-19-4
• Molecular Formula: C11H12ClFN2O2
• Molecular Weight: 258.68
• Mol File: 473258-19-4.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Propanoic acid, 2-[(3-chloro-4-fluorophenyl)hydrazono]-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Propanoic acid, 2-[(3-chloro-4-fluorophenyl)hydrazono]-, ethyl ester(473258-19-4)
• EPA Substance Registry System: Propanoic acid, 2-[(3-chloro-4-fluorophenyl)hydrazono]-, ethyl ester(473258-19-4)

Safety Data

• Hazardous Substances Data: 473258-19-4(Hazardous Substances Data)

Upstream product

• 367-21-5 3-chloro-4-fluorophenylamine 
• 617-35-6 2-oxo-propionic acid ethyl ester 
• 84282-78-0 3-chloro-4-fluorophenyl hydrazine 

Downstream Products

• 169674-00-4 ethyl 6-chloro-5-fluoro-1H-indole-2-carboxylate 

Relevant articles and documents

Indole derivative and medical application thereof

The invention discloses an indole compound with FABP4/5 inhibitory activity and a preparation method and medical application of the indole compound. The indole compound is a compound of which the structural formula is shown as a formula I, and pharmaceutically acceptable salt or ester or solvate of the compound. The compound shown in the formula I is a novel FABP4/5 inhibitor and can be used for preparing medicines for preventing or treating FABP4/5 related diseases.

NOVEL 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for mating the compounds.

NOVEL INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.